More about
Afamitresgene Autoleucel
News
June 04, 2021
3 min read
Save
Gene-edited T-cell therapy shows ‘promising efficacy’ for rare sarcomas
Nearly 40% of patients with advanced or metastatic synovial sarcoma or myxoid/round cell liposarcoma responded to therapy with afamitresgene autoleucel, according to results of a phase 2 study.